Business · 12/01/2004Updated: 10/17/2026 · 1 min read
FDA Amends Notice for Psychopharmacologic Drugs Advisory Committee and Pediatric Subcommittee
Summary
The FDA has amended a notice related to the Psychopharmacologic Drugs Advisory Committee and the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee. The committee will discuss the safety and efficacy of certain psychopharmacologic drugs in children.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →